Godavari Drugs

44
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
120.00
0.00 (0.00%)
BSENSE

Jul 17, 03:30 PM

BSE+NSE Vol: 2.94 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024

Compare Profit and Loss Results of Godavari Drugs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
113.00
116.00
-3.00
-2.59%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
113.00
116.00
-3.00
-2.59%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-8.00
5.00
62.50%
Raw Materials Consumed
85.00
60.00
25.00
41.67%
Power & Fuel Cost
6.00
10.00
-4.00
-40.00%
Employee Cost
5.00
12.00
-7.00
-58.33%
Operating Expenses
3.00
14.00
-11.00
-78.57%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
4.00
-4.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
2.00
1.00
50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
101.00
99.00
2.00
2.02%
Operating Profit (PBDIT) excl Other Income
11.00
16.00
-5.00
-31.25%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
12.00
18.00
-6.00
-33.33%
Interest
4.00
6.00
-2.00
-33.33%
Profit before Depriciation and Tax
8.00
12.00
-4.00
-33.33%
Depreciation
2.00
5.00
-3.00
-60.00%
Profit Before Taxation & Exceptional Items
5.00
6.00
-1.00
-16.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
6.00
-1.00
-16.67%
Provision for Tax
1.00
1.00
0.00
0.00%
Profit After Tax
4.00
5.00
-1.00
-20.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
20.00
0.00
0.00%
Profit Available for appropriations
24.00
25.00
-1.00
-4.00%
Appropriations
24.00
25.00
-1.00
-4.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.82
4.1
1.72
41.95%
Profit And Loss - Net Sales
Net Sales 113.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024

Profit And Loss - Interest
Interest 4.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024